Newsletters & Media

Media Releases

2022

2022/07

InSight: July Update

2022/04

InSight: Rosebud on-site inspection by Health Canada

2022/04

InSight: BC Cannabis Stores now supplying Rosebud’s first crop

2022/04

InSight: Sales Amendment

2022/04

InSight: Health Canada update

2022/03

InSight: Grow-Make-Sell Update

2022/03

InSight: Annual General Meeting update

2022/03

InSight: Rosebud’s first crop sold to Licensed Processor

2022/03

InSight: Cocos Pure International Distribution

2022/02

InSight: Rosebud implements seed-to-sale software

2022/02

InSight: Rosebud’s First Crop ‘Grape Kush Mint’ Results

2022/02

InSight: New plants arrive at Rosebud

2022/01

InSight: Rosebud welcomes new Quality Assurance Person

2022/01

InSight: Letter from the Founder and President, setting sails for 2022

2021

2021/11

InSight: Week 7 of Growth and Cultivation & Processing Sales Amendment

2021/10

InSight: Grow room time-lapse and AGM Investor Q & A

2021/10

InSight: Crop Enters Flower Cycle

2021/09

InSight: New Cocos Pure EU Order & final call for Convertible Debenture investment

2021/09

InSight: Official closure of Convertible Debenture

2021/09

InSight: Debenture closure

2021/09

InSight: Clones recieved from licensed Tissue Culture Nursery

2021/08

InSight: Letter from the President and Founder

2021/08

InSight: Rosebud Medical Sale with Possession

2021/08

InSight: Starting material Master Grower

2021/08

InSight: Rosebud Productions Receives License!

2021/07

InSight: Rosebud Productions application passes Health Canada final review panel

2021/07

InSight: Health Canada Status Update at Rosebud Productions

2021/07

InSight: Time-Lapse Completion of Rosebud Racks and Lights

2021/06

InSight: In Person Site Tours

2021/06

InSight: Fundraising Update

2021/06

InSight: Cocos Pure Shipment

2021/06

InSight: Arrival And Installation Of Rosebud Racks

2021/06

InSight: CBD Extraction Agreement

2021/05

InSight For Stakeholders: Rosebud Final Building Inspection complete

2021/05

InSight For Stakeholders: A change to the way we deliver our news

2021/03

InSight For Stakeholders: Fundraising Update

2021/03

InSight For Stakeholders: Rosebud Productions Completes RMI

2021/03

InSight For Stakeholders: Rosebud Productions Request More Information

2021/02

InSight For Stakeholders: Rosebud Application Assigned To An Agent

2021/02

InSight For Stakeholders: NG Biomed Brokers CBD Hemp Extraction Agreement

2021/02

InSight For Stakeholders: NG Biomed Financing

2021/01

InSight for Stakeholders: NG Biomed sells last Mission BC property

2021/01

InSight for Stakeholders: NG Biomed enters agreement with MorFund Financial Inc.

2021/01

InSight for Stakeholders: Transfer of Hemp biomass

2021/01

InSight For Stakeholders | General Contractor Engaged For Equipment Installation At Rosebud Site

2020

2020/12

Season Greetings From NGB | Health Canada Has Received Evidence

2020/12

InSight | Rosebud Evidence submitted to Health Canada

2020/12

Reporting a breach of security

2020/12

InSight for Stakeholders: Site Evidence build-out complete

2020/11

InSight for Stakeholders: Sale of NG Biomed’s Mission BC properties

2020/01

Notice to Shareholders | New Offer

2020/01

InSight for Stakeholders | Building Permit

2019

2019/12

InSight for Stakeholders | CSE Submission

2019/12

InSight for Stakeholders | Richmond Rosebud Rezoning

2019/05

InSight for Stakeholders | Rosebud Site Evidence Package

Newsletters

2021

2021/04 Vol 3 No 1

Final inspections booked by May 15th, Health Canada Agent Assigned, RMI received.

2021/01 Vol 2 No 4

Site Evidence package to Health Canada. Build-out continues.

2020

2020/10 Vol 2 No 3

Site Evidence package to Health Canada. Build-out continues.

2020/07 Vol 2 No 2

Under Construction and Initial Site Inspections Passed. Lease Agreement to Support Future Cash-Flow Needs.

2020/04 Vol 2 No 1

Site Evidence Build-out continues. NG Biomed ensures autonomy over the real estate containing their operations.

2019

2019/10 Vol 1 No 4

Dr. Bin Huang at NG Biomed. Trichomes begin to unfold beneath the Fraser Valley.

2019/07 Vol 1 No 3

NG Biomed received industrial hemp license from Health Canada. Updates to the Cannabis Act- edibles, concentrates and topicals.

2019/02 Vol 1 No 2

NG Biomed in the news: re-zoning. Cocos Pure and NG Biomed in a budding partnership. NG biomed Mission Greens site.

2018

2018/09 Vol 1 No 1

Cannabis Act takes effect. New acquisition. Becoming a Pubco. Property re-zoning. University of British Columbia partnership.

2017

2017/09 Vol 1 No 1

Application Status. Mergers and acquisitions. Industry news.

Media Links

A Guide to Being a Licensed Marijuana Producer (w/ Justin Dhaliwal)

The market has been projected to be worth more than $10 billion. For some, that suggests the marijuana industry is going to be a gold rush – that is until you look inside.

Interview – Cannabizdaily Speaks With NG Biomed – Canadian Licensed Producer – About Medical Cannabis, Legislation, and Opportunities Abroad – CannabizDaily.co

NG Biomed is currently in the late stages of being approved as a Licensed Producer of Medical cannabis for the Canadian marketplace. Please enlighten us with some background on the company?

cannabizdaily.co

Medical cannabis company donates $1 million to explore plant’s healing potential

Medical marijuana producer National Green Biomed Ltd. has committed $1 million to the University of British Columbia to allow researchers to study the therapeutic effects of cannabis. The company has made an application and is awaiting approval from Health Canada to produce and sell medical marijuana.

Richmond council allows medical cannabis facility

Richmond city council voted in favour of a new medical cannabis facility Wednesday.